Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

This study has suspended participant recruitment.
(Temporarily stopped for assessment)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01623869
First received: June 17, 2012
Last updated: September 16, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)